ABL Bio (Korea) Market Value

298380 Stock  KRW 28,800  500.00  1.71%   
ABL Bio's market value is the price at which a share of ABL Bio trades on a public exchange. It measures the collective expectations of ABL Bio investors about its performance. ABL Bio is trading at 28800.00 as of the 9th of December 2024, a 1.71 percent decrease since the beginning of the trading day. The stock's open price was 29300.0.
With this module, you can estimate the performance of a buy and hold strategy of ABL Bio and determine expected loss or profit from investing in ABL Bio over a given investment horizon. Check out ABL Bio Correlation, ABL Bio Volatility and ABL Bio Alpha and Beta module to complement your research on ABL Bio.
Symbol

Please note, there is a significant difference between ABL Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABL Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABL Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ABL Bio 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ABL Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ABL Bio.
0.00
12/20/2022
No Change 0.00  0.0 
In 1 year 11 months and 21 days
12/09/2024
0.00
If you would invest  0.00  in ABL Bio on December 20, 2022 and sell it all today you would earn a total of 0.00 from holding ABL Bio or generate 0.0% return on investment in ABL Bio over 720 days. ABL Bio is related to or competes with Genexine. ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurod... More

ABL Bio Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ABL Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ABL Bio upside and downside potential and time the market with a certain degree of confidence.

ABL Bio Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ABL Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ABL Bio's standard deviation. In reality, there are many statistical measures that can use ABL Bio historical prices to predict the future ABL Bio's volatility.
Hype
Prediction
LowEstimatedHigh
28,79628,80028,804
Details
Intrinsic
Valuation
LowRealHigh
26,36126,36631,680
Details
Naive
Forecast
LowNextHigh
31,75931,76431,768
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
22,69430,96939,243
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ABL Bio. Your research has to be compared to or analyzed against ABL Bio's peers to derive any actionable benefits. When done correctly, ABL Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ABL Bio.

ABL Bio Backtested Returns

At this point, ABL Bio is very steady. ABL Bio secures Sharpe Ratio (or Efficiency) of 0.0211, which signifies that the company had a 0.0211% return per unit of return volatility over the last 3 months. We have found twenty-four technical indicators for ABL Bio, which you can use to evaluate the volatility of the entity. Please confirm ABL Bio's Standard Deviation of 4.41, mean deviation of 3.44, and Variance of 19.47 to double-check if the risk estimate we provide is consistent with the expected return of 0.0917%. ABL Bio has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ABL Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding ABL Bio is expected to be smaller as well. ABL Bio at this time shows a risk of 4.35%. Please confirm ABL Bio coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if ABL Bio will be following its price patterns.

Auto-correlation

    
  -0.67  

Very good reverse predictability

ABL Bio has very good reverse predictability. Overlapping area represents the amount of predictability between ABL Bio time series from 20th of December 2022 to 15th of December 2023 and 15th of December 2023 to 9th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ABL Bio price movement. The serial correlation of -0.67 indicates that around 67.0% of current ABL Bio price fluctuation can be explain by its past prices.
Correlation Coefficient-0.67
Spearman Rank Test-0.6
Residual Average0.0
Price Variance26.5 M

ABL Bio lagged returns against current returns

Autocorrelation, which is ABL Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ABL Bio's stock expected returns. We can calculate the autocorrelation of ABL Bio returns to help us make a trade decision. For example, suppose you find that ABL Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

ABL Bio regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ABL Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ABL Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ABL Bio stock over time.
   Current vs Lagged Prices   
       Timeline  

ABL Bio Lagged Returns

When evaluating ABL Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ABL Bio stock have on its future price. ABL Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ABL Bio autocorrelation shows the relationship between ABL Bio stock current value and its past values and can show if there is a momentum factor associated with investing in ABL Bio.
   Regressed Prices   
       Timeline  

Pair Trading with ABL Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABL Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABL Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with ABL Stock

  0.63207940 Samsung BiologicsPairCorr
  0.91326030 Sk BiopharmaceuticalsPairCorr
  0.7144510 Green Cross LabPairCorr
The ability to find closely correlated positions to ABL Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABL Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABL Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABL Bio to buy it.
The correlation of ABL Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABL Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABL Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABL Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in ABL Stock

ABL Bio financial ratios help investors to determine whether ABL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABL with respect to the benefits of owning ABL Bio security.